tirzepatide cardiovascular outcomes trial 2024 In patients with type 2 diabetes and atherosclerotic disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Tirzepatide for Obesity Treatment and

If you are in Connecticut and want guidance on whether semaglutide or tirzepatide may be appropriate for you, contact BioRestore to schedule a medical consultation

People in more economically developed populations had more body fat, higher body mass, and higher body mass index

4), inhibiting ferroptosis and contributing to the growth of ER+ breast cancer cells

Gallbladder Problems : Studies have linked GLP-1 medications like Ozempic to an increased risk of gallstones and gallbladder disease

Chronos Behavioral Health & Wellness

IN A HUMAN RESEARCH STUDY Participants in the RiboCeine group experienced an increase in serum Glutathione levels in as little as 28 days